A dual function activity-dependent, muscle-specific enhancer from rat nicotinic acetylcholine receptor δ-subunit gene by Walke, Wade et al.
A Dual Function Activity-Dependent, Muscle-Specific 
Enhancer from Rat Nicotinic Acetylcholine Receptor 
&Subunit Gene 
Wade Walke, Guozhi Xiao, and Daniel Goldman* 
Mental Health Research Institute and Department of Biological Chemistry, The University of Michigan, 
Ann Arbor, Michigan 481 09 
SUMMARY 
Nicotinic acetylcholine receptors (nAChR) mediate 
communication between nerve and muscle. The expres- 
sion of these receptors increases dramatically during 
muscle development when myoblasts are fusing into mul- 
tinucleated myotubes. The molecular mechanisms medi- 
ating this muscle developmental stage specific expres- 
sion are not well understood. W e  report here the identi- 
fication of nAChR b-subunit promoter DNA sequences 
that differentially interact with nuclear proteins isolated 
from myoblasts, myotubes, and nonmuscle cells. The 
functional role these sequences play in mediating muscle- 
specific expression was explored using mutagenesis and 
enhancer assays. These studies resulted in the identifi- 
INTRODUCTION 
The muscle nicotinic acetylcholine receptor 
(nAChR) is a pentameric integral membrane pro- 
tein that functions as a ligand-gated ion channel. I t  
is composed of four different subunits with a stoi- 
chiometry of a&( c ) &  Acetylcholine binds to the 
01 subunits to cause a conformational change in the 
receptor that results in ion flow across the mem- 
brane. In muscle this conductance activates volt- 
age-dependent sodium channels ultimately result- 
ing in muscle contraction. 
In adult skeletal muscle nAChRs are localized 
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cation of a 47-bp muscle-specific enhancer that mediates 
increased expression of the nAChR b-subunit gene during 
myotube formation. This enhancer contains an E-box and 
a n  element with similarity to the SV40 core enhancer 
(SVCE).  Point mutations throughout this 47-bp en- 
hancer showed that the E-box and the SVCE sequence 
are both necessary for conferring muscle-specific expres- 
sion onto a heterologous promoter. Interestingly, this 
same DNA sequence also functions as an activity-depen- 
dent enhancer. 
Keywords: muscle-specific enhancer, activity-dependent 
enhancer, muscle development, gene expression, nico- 
tinic acetylcholine receptor. 
8 1996 John Wiky & Sons, Inc. 
to the neuromuscular junction. However, muscle 
denervation results in a large increase in nAChR 
expression throughout the muscle fiber. Similar to 
the increase in expression following muscle dener- 
vation, nAChRs are also induced during muscle 
development when myoblasts fuse into multinu- 
cleated myotubes (Bevan and Steinbach, 1977). 
These increases in receptor protein are largely ac- 
counted for by changes in nAChR subunit gene ex- 
pression (Buonanno and Merlie, 1986; Tsay and 
Schmidt, 1989). It has been suggested that the 
mechanisms mediating developmental induction 
of nAChR gene expression may be similar to those 
mediating induction of these genes following mus- 
cle denervation (Simon and Burden, 1993). Con- 
sistent with this idea is the identification of myo- 
genic factor binding E-box sequences (CANNTG) 
that participate in both muscle developmental 
stage specific and activity-dependent expression of 
nAChR genes (Berberich et al., 1993; Bessereau et 
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al., 1993, 1994; Numberger et al., 1991; Piette et 
al., 1990; Prody and Merlie, 1991; Wang et al., 
1988; Tang et al., 1994; Su et al., I995 ). However, 
because many muscle-specific genes contain these 
E-boxes it is likely that other elements are also nec- 
essary for mediating activity-dependent control of 
gene expression and perhaps developmental stage 
specific expression. We have begun to identify the 
elements mediating activity-dependent expression 
ofthe nAChR b-subunit gene (Walke et al., 1996). 
In this report we focus on DNA elements mediat- 
ing developmental stage specific expression of the 6 
gene. 
Among the rodent nAChR subunit genes, that 
encoding the 6 subunit is unique in that it requires 
a region of DNA containing a single E-box for mus- 
cle-specific expression (Baldwin and Burden, 1988; 
Chahine et al., 1992). Similar to other character- 
ized E-boxes, the mouse &gene’s E-box contributes 
to high level &subunit gene expression in myo- 
tubes. However, unique to this E-box is its ability 
to also suppress &subunit gene expression in myo- 
blasts and other nonmuscle cells (Simon and Bur- 
den, 1993). Another unique feature of this gene is 
its near wild-type expression in myogenin deficient 
mice (Hasty et al., 1993). In contrast the nAChR 
a gene, along with other muscle-specific genes, is 
shut off in these animals. These results suggest a 
unique mode of regulation of the &subunit gene 
in muscle and nonmuscle cells and underscore the 
importance of characterizing the mechanisms con- 
trolling its muscle-specific expression. 
In order to identify mechanisms contributing to 
muscle-specific expression of the b-subunit gene, it 
is necessary to define the DNA elements that are 
involved in this specific expression pattern. Al- 
though the E-box is certainly one ofthese elements, 
we show here that it is not sufficient for conferring 
this pattern of expression onto a heterologous pro- 
moter. To identify additional elements contribut- 
ing to the muscle-specific expression of this gene 
we used methylation interference assays to identify 
sequences within the rat &subunit gene’s promoter 
that differentially bind muscle- and nonmuscle-de- 
rived nuclear proteins. These regions of DNA were 
then tested in functional assays to determine their 
role in mediating muscle-specific gene expression. 
These studies identified a 47-bp muscle-specific en- 
hancer of the rat &subunit gene. This enhancer 
contains an E-box and a sequence with similarity 
to the SV40 core enhancer (SVCE) (Khoury and 
Gruss, 1983 ), both of which are necessary for mus- 
cle-specific enhancer activity. This enhancer was 
recently shown to also confer muscle activity-de- 
pendent regulated expression onto a heterologous 
promoter (Walke et al., 1996). 
MATERIALS AND METHODS 
Plasmids 
For the enhancer experiments a minimal enkephalin 
promoter construct (MEK pXP2) was made by placing 
a 135-bp fragment ofthe enkaphalin promoter (Comb et 
al., 1986), extending from nucleotides -72 to +60 rela- 
tive to the transcriptional start site, in the Smu I and filled 
in Bg/ 11 sites of the pXP2 vector driving luciferase ex- 
pression (Nordeen, 1988). Short oligonucleotides span- 
ning the sequences from the 6 promoter (Chahine et al., 
1992) as indicated in Figures 3-5 ( 6  - 1061 -72, 6 -8 1 / 
-32, 6 -471-1, 6 -25/+10) were synthesized with a 
BurnHl restriction enzyme site included on the 5‘ end of 
the oligo and a Bgl I1 restriction enzyme site included on 
the 3‘ end. These oligos were then placed in the BamHI 
site of the MEK pXP2 construct in both orientations. 
The oligos were also placed into the promoterless pXP2 
plasmid to test for promoter activity, and in addition 
subcloned into BSSK( + ) for sequence determination. 
For the mutation and deletion studies on the 6 pro- 
moter we used the pXP 6550/4 construct described pre- 
viously (Chahine et al., 1992), containing sequences 
-550 to f l  1 relative to the transcriptional start site. 
Scanner-linker mutations (slm) were generated by doing 
a series of 5’ and 3’ deletions on this construct using exo- 
nuclease 111. These deleted DNAs were sequenced in or- 
der to define their 5’ and 3’ ends. Deletions that had 3’ 
ends exactly 17 bp upstream of an appropriate 5 ’ deletion 
were ligated with a 17-bp linker inserted in between. One 
exception was 6 -550 slm -441-29, which only has a 
16-bp deletion between ends, with a 17-bp linker in- 
serted. The sequence of the linker is CAGATCTCG- 
AGCTCCAC. This linker contains three unique restric- 
tion sites: Bg/ 11, Xho I, and Sac I.  These scanner-linker 
mutations were also assayed in a 6-promoter construct 
whose 5’ end was at position - 119. These constructs 
were generated by polymerase chain reaction (PCR) am- 
plification using an oligonucleotide with a 5’ end at - 1 19 
and another oligonucleotide complimentary to plasmid 
sequence flanking the 3’ end of the 6-promoter insert. 
The PCR fragment was then cut with HindIII and cloned 
into the Smu IIHindIII sites of BSSK( +) for sequencing 
and subsequently cut with BamHIIHindIII and sub- 
cloned into the BurnHIIHindIII sites of the pXPl vec- 
tor. Internal deletions of the 6 promoter were created by 
cutting the various scanner-linker mutants with Xho I, 
which cuts in the linker, and HindIII to remove the 3’ 
ends, and then ligating different 3’ ends with different 5’ 
ends as indicated in Figure 5. All mutations and dele- 
tions generated were also subcloned into BSSK( +) for 
sequence analysis. 
MCKCAT and SV2CAT constructs were used to nor- 
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malize for transfection efficiency and were described pre- 
viously (Chahine et al., 1992; Walke et al., 1994). 
mixed for 60 min at 4°C. Precipitated proteins were iso- 
lated by centrifugation in a Ti 45 rotor (Beckman) at 
18,000 rpm for 30 min at 4°C. The pellet was then dis- 
olved in buffer A and dialyzed overnight at 4°C against 
100 volumes of buffer A. Cell Culture and Transfections 
For the transient transfection assays, 60-mm dishes were 
seeded with either C2C12 myoblasts or NIH3T3 cells at 
a density of 1 X lo4 cells per dish. C2C12 cells were 
grown in Dulbeccos's modified Eagle's medium (DMEM) 
supplemented with 20% fetal bovine serum (FBS) and 
antibiotics/antimycotic. NIH3T3 cells were grown in 
DMEM supplemented with 10% FBS and antibiotics/ 
antimycotic. All cells were grown in a humidified incu- 
bator at 37°C in 5% C02.  Cells were transfected 24 h after 
plating using the calcium phosphate method previously 
described (Wigler et al., 1979) with the following modi- 
fications. In all experiments 10 pg of &promoter con- 
structs were cotransfected with 20 pg of either SV2CAT 
or MEKCAT vector. The CAT vector and subsequent 
CAT assays were used to normalize for variations in 
transfection efficiency between plates. In short, our pro- 
cedure was to wash cells once with DMEM without se- 
rum and then place 3 mL of DMEM without serum onto 
plates. DNA-calcium phosphate precipitates (0.5 mL) 
were then added to cells dropwise and allowed to incu- 
bate with cells for 1 h. Cells were then glycerol shocked 
for 2 min with a solution of 1X HBS (140 m M  NaCI, 
23 mMHEPES, pH 7.1, and0.75 mA4Na2HP04), 15% 
glycerol, and fed fresh growth media. The media was 
changed 12 h after glycerol shock and daily thereafter. 
To induce fusion of myoblasts media was changed to 
DMEM containing 5% horse serum at 12 h after glycerol 
shock. Cells were harvested for luciferase and CAT as- 
says 2-3 days after glycerol shock by lysis in 200 pL of 
0.25 MTris-CI (pH 7.5), 1% Triton-X. Assays were per- 
formed as previously described (Brasier et al., 1989; 
Neumann et al., 1987). All transfections were performed 
in triplicate and repeated at least twice. 
Dimethylsulfate (DMS) DNA Footprinting 
DNA probes were made from a &promoter clone con- 
taining 102 bp upstream of the transcriptional start site. 
One end of the probe was 32P labeled by Klenow fill-in 
reaction, isolated on a polyacrylamide gel, eluted, and 
purified by pheno1:chloroform:isoamyl alcohol (25:24: 
1 ) extraction and ethanol precipitation. Crude nuclear 
extracts were prepared by the method of Dignam et al. 
(1983). In some experiments crude nuclear extracts 
were partially purified by DEAE Sephadex column frac- 
tionation and ammonium sulfate precipitation as fol- 
lows. Thirty milligrams of crude nuclear protein was 
added to a DEAE Sephadex A-50 column. The column 
was washed with 150 mL of buffer A [ 20 m M  HEPES, 
(pH 7.9 at 4"C), 20% glycerol, 0.2 mMEDTA, 0.2 m M  
PMSF, 0.5 mMdithiothreilol (DTT) 0.1 MNaCI]. The 
column flow through containing the nuclear proteins 
was adjusted to 33% ammonium sulfate and then slowly 
DNA-protein binding reactions and DMS foot- 
printing were performed by incubating 12.5-200 p g  of 
protein from nuclear extracts in 125 pL of binding buffer 
[25 m M  HEPES, pH 7.9, 100 mMNaCI, 10% glycerol, 
1 mg/mL BSA, 0.5 m M  DTT, 0.2 m M  PMSF, 50 pgl  
mL poly(d1-dC)] with 20,000 cpm of labeled probe 
( - 0.1-0.2 ng) for 20 min at room temperature. After 
the binding reaction, samples were treated with 75 p L  
of DMS diluted 1:200 in DMS reaction buffer (50 m M  
sodium cacodylate, pH 8.0, 1 m M  EDTA) for 2 minutes 
at 25°C. DMS reaction was terminated with DMS stop 
solution ( 1.5 m M  sodium acetate, pH 7.0, 1 M (3-mer- 
captoethanol, 250 g / m L  yeast tRNA). Samples were 
then phenol/chloroform extracted and precipitated with 
ethanol. Strand cleavage at methylated guanine residues 
was then carried out as outlined in the chemical DNA 
sequencing technique of Maxam and Gilbert ( 1980). 
RESULTS 
Identification of Putative &Promoter 
Regulatory Elements by (DMS) 
DNA Footprinting 
We previously identified a 82-bp sequence of the 
rat &subunit gene that contains all the elements 
necessary for muscle developmental stage specific 
expression (Chahine et al., 1992). In order to iden- 
tify potential regulatory elements residing within 
this piece of DNA we used a DNA footprinting pro- 
cedure that employs DMS as a chemical probe for 
regions of DNA bound by protein. DMS chemi- 
cally modifies DNA by methylating guanine resi- 
dues and subsequent treatment with pipendine 
causes chemical strand scission at the modified res- 
idues. Therefore, only the interactions of protein 
factors with guanine residues can be observed using 
this method. Protein factors binding to DNA se- 
quences can have two effects on modifying DMS 
methylation patterns. One effect is that of protec- 
tion from DMS methylation, while the other is that 
of hypermethylation due to the creation of hy- 
drophobic pockets near the affected residues. 
Incubation of the DNA probe with myotube 
nuclear extract identified a number of residues that 
were either protected from DMS methylation or 
hypennethylated (Fig. 1 ).. Many of these residues 
appear to reside within consensus sequences com- 
prising known transcription factor binding sites. 
These sites include an E-box sequence (CACCTG) 
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Figure 1 DMS footprinting identifies putative regulatory elements in the 6-subunit gene’s 5’ 
flanking DNA. Results from DMS footprinting analysis of the 102-bp &promoter region using 
partially purified nuclear extracts from either C2C 12 myotubes, myoblasts, or NIH3T3 cells is 
shown. Binding to both the coding (4  ) a n d  noncoding strand (- ) are shown. Regions contain- 
ing guanine residues that were protected (0) or hypermethylated ( @ )  are indicated with lines 
and labeled along the side. Note that gels showing myoblasts and fibroblasts results were run 
slightly longer than that showing myotube results. AP, putative AP2 element; X, enhancer X 
region; SV, SV40 core enhancerlike sequence; Sp, Sp I-like element: E, E-box sequence; and I, 
initiator sequence. 
centered 20 bp upstream of the transcription start 
site (nt -20); an Spl -like sequence (GCCGCC) lo- 
cated at nt -27; a sequence similar to the SV40 
core enhancer (SVCE) (CTTTCCAAACCCCT) 
(Khoury and Gruss, 1983) at nt -40; a region bear- 
ing no similarity to any recognizable transcription 
factor binding sequence from nt -50 to nt -70, 
referred to as enhancer X; an AP2 element 
(CCCCACCC) at nt -95; and an initiator se- 
quence (Smale and Baltimore, 1989) centered at 
nt -1 (Fig. 2) .  
Comparison of the methylation interference 
pattern between myotubes, myoblasts, and fibro- 
blasts identifies some potentially important differ- 
ences in protein binding (summarized in Fig. 2 ) .  
First, we were not able to observe myotube-depen- 
dent protection of the 3 G residues of the E-box in 
the (-) strand when myoblast or fibroblast nuclear 
extracts were used in the assay. Second although 
myoblast and fibroblast extracts caused a hyper- 
methylation ofa G residue in the Sp 1 -like sequence 
on the (-) strand, they do not cause protection of 
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Figure 2 Summary of footprinting analysis using nuclear extracts from C2C12 myotube and 
NIH3T3 cells. The D N A  sequence of the &subunit gene’s 5’ flanking D N A  extending from 
nucleotides - 102 to + 1 1 relative to the transcriptional start site (arrow) is shown for both the 
coding (+) and noncoding ( -) strands. ( A )  Summary of footprinting data using myotube 
nuclear extracts. ( B )  Summary of footprinting data using myoblast/NIH3T3 cell nuclear ex- 
tracts. Interactions of nuclear factors are indicated by circles above or below the sequence. 
Closed circles indicate hypersensitive residues while open circles represent protected residues. 
Lines and identifiers above the sequences are putative binding sites for nuclear factors de- 
scribed in the text. 
the two other G residues that are observed with my- 
otube extracts. Third, the hypersensitive sites, ob- 
served in the SV region of the (- ) strand using my- 
otube nuclear extracts, are not hypermethylated 
when myoblast or fibroblast extracts are employed. 
Fourth, the AP region of the (-) strand is both hy- 
permethylated and protected when myotube ex- 
tracts are used, while only protections are observed 
when myoblast and fibroblast extracts are used in 
the methylation interference assay. In general, 
nuclear extracts derived from myoblasts and fi- 
broblasts generated similar methylation interfer- 
ence patterns, suggesting similar proteins from 
these two cell types may be interacting with the 
DNA. In contrast, a significantly different pattern 
was generated when myotube nuclear extracts were 
employed, suggesting that myotube-specific factors 
mediate this specificity. Figure 2 summarizes the 
methylation interference patterns generated using 
these various extracts. 
Multiple Elements within 82-bp 6 
Promoter Are Necessary for Expression 
in Myotubes and Repression in 
Fibroblasts 
We previously identified a small piece of b-pro- 
moter DNA extending 82 nucleotides upstream of 
the transcriptional start site that retained a muscle- 
specific expression profile (Chahine et al., 1992). 
This fragment lacks a putative AP2 element that is 
necessary for maximal &promoter activity (Cha- 
hine et al., 1992). In order to identify sequences 
within this 82-bp promoter fragment that are nec- 
essary for muscle-specific expression, we created 
several internal deletions and mutations. Scanner- 
linker mutations were made in which 17 bp of se- 
quence from within the 6 82-bp region was deleted 
and replaced by 17 bp of linker DNA. To insure 
that specific effects were not contributed by the in- 
troduced linker, experiments were repeated in con- 
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Figure 3 Identification of &promoter sequences mediating muscle-specific expression. Vari- 
ous scanner-linker mutations and deletions are represented schematically, with the numbers 
indicating the sequences replaced, deleted, or present. These expression vectors were cotrans- 
fected with SV2CAT into C2C12 myotubes (MT) or NIH3T3 fibroblasts (FB). After 48 h cells 
were harvested and luciferase and CAT activities were determined. Results are shown with 
standard deviations on the right-hand side of the figure. Values are reported as a percentage of 
6-550 wt expression in myotubes (MT)  or fibroblasts (FB). In addition the ratio of expression 
myotubes/fibrolasts ( MT/FB) is provided. Numbers in parenthesis indicate the number of 
times each experiment was performed. Each experiment consisted of three replicas. ( * )  These 
clones were also tested in primary myotubes with similar results. with the exception of the E- 
box mutation (6 -550  slm -2 l / - 5 ) ,  which showed only 60% activity as compared to the wild- 
type promoter. (+) These scanner linker mutations with 5' ends at -1 19 instead of -550 
showed similar results. Boxes and rectangles representing putative regulatory elements are 
shown to help identify DNA regions containing mutations and are not necessarily drawn to 
scale. 
structs in which the linker was removed. Similar 
results were obtained regardless of the presence or 
absence of linker. The different deletion and muta- 
tion constructs and their expression in myotubes 
and fibroblasts are indicated in Figure 3.  
A scanner linker mutation residing in the en- 
hancer X element (which spans nt -70 to -50 
based on footprinting and expression assays) sig- 
nificantly reduced promoter activity in both myo- 
tubes and fibroblasts (clone 6 -550 slm -8 1 / -65; 
Fig. 3 ) .  In contrast, deletion or mutation of DNA 
containing the E-box element (clones 6 -550 slm 
-21/-5 and 6 -81/-32; Fig. 3 )  consistently re- 
sulted in increased promoter activity in fibroblasts 
(Fig. 3 ) .  Both these results are consistent with mu- 
tational analysis of similar regions of the mouse 6 
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promoter (Simon and Burden, 1993). However, 
unlike that found for the mouse promoter (Simon 
and Burden, 1993; W.W. and D.G. unpub. 
observ.), E-box mutations in the rat promoter had 
little effect on expression in the myotubes ( 6  -550 
slm -2 1 / -5 in Fig. 3 ). This latter effect was not a 
result of incomplete cell differentiation or stability 
of the reporter gene because time course experi- 
ments using the human growth hormone reporter 
gene gave similar results (W.W. and D.G., unpub. 
oberv.) . 
Of the scanner-linker mutations shown in Fig- 
ure 3, 6 -550 slm -2 1 / - 5 ,  which eliminates the 
E-box sequence and 3‘ flanking DNA, showed the 
most dramatic effect on muscle-specific expression, 
suggesting that the E-box is necessary for this ex- 
pression profile. However, this region of DNA on 
its own is insufficient in directing muscle-specific 
expression, yet expresses at near wild-type levels in 
fibroblasts ( 6  -25 / + 10; Fig. 3 ) . In contrast, 6 -47 / 
- 1 does contain muscle-specific promoter activity, 
suggesting muscle specificity results from multiple 
elements within this region of DNA. Finally, se- 
quences spanning residues -8 1 thru -32, although 
containing promoter activity, do not confer a mus- 
cle-specific expression profile (6  -8 1 / -32; Fig. 3). 
The increased level of expression of 6 -8 1 / -32 in 
fibroblasts is consistent with other constructs lack- 
ing an E-box ( 6  -550 slm -21/5 in Fig. 3). It 
should be noted that constructs 6 -47 / - 1 and 6 
-82/ -32 lack a complete initiator sequence that is 
believed to be important for transcript initiation, 
and therefore makes interpretation of the above re- 
sults difficult. In order to verify that these se- 
quences are able to regulate promoter activity, we 
created chimeric promoters containing these se- 
quences in front of the minimal enkephalin pro- 
moter (see below and Fig. 4). 
Identification of a General and a Muscle- 
Specific Enhancer within 82-bp 
&Subunit Promoter 
The above described mutations along with the 
DNA footprinting studies identified important reg- 
ulatory regions of the 6 promoter. Many of these 
mutations appeared to modestly contribute to 
muscle specific expression (Fig. 3), perhaps sug- 
gesting multiple redundant elements. However, de- 
letion of DNA from the 5’end ofthis promoter sug- 
gested that one set of elements conferring muscle 
specificity resided within the first 47 bp of the 6 pro- 
moter ( 6  -47 / - 1 ; Fig. 3 ) .  To determine if this and 
any other regions functioned as muscle-specific en- 
hancers, we placed various fragments from the 6 
promoter in front of a minimal enkephalin pro- 
moter ( MEK) driving luciferase expression. These 
constructs were then transfected into both C2C 12 
myotubes and NIH3T3 cells. Results of these ex- 
periments are shown in Figure 4. Expression is rep- 
resented as a percentage relative to the minimal en- 
kephalin promoter. Also shown is the myoblast/ 
fibroblast expression ratio. This analysis revealed 
two regions that are able to enhance expression 
from the minimal enkephalin promoter. 
The region from nt -81 to nt -32, containing 
DNA labeled as enhancer X and SVCE, functions 
as an enhancer in both muscle and fibroblast cells 
increasing expression by 9.5-fold and 14-fold 
above MEK expression in each cell type, respec- 
tively (clone 6 -8 1 / -32 MEK; Fig. 4). This region 
also functioned in the reverse orientation, although 
to a slightly lesser extent, increasing expression by 
7.2-fold in muscle and 3.9-fold in fibroblast like 
cells(c1one 6 -32/-81 MEK; Fig. 4). 
Interestingly, the region spanning nucleotides 
-47 to - I ,  which contains putative E-box, Spl- 
like, and SVCE elements, functions as a strong 
muscle-specific enhancer. This region of DNA in- 
creases the MEK promoter activity about 26-fold 
in muscle cells, while only increasing it 1.4-fold in 
fibroblasts (clone 6 -47/-1 MEK; Fig. 4) .  This 
muscle-specific expression is retained when this 
same region is used in the reverse orientation ex- 
cept that the enhancement in muscle is smaller at 
7.1-fold(clone 6 -1/-47 MEK; Fig. 4).  
The region spanning nucleotides -106 to -72 
contains a putative AP2 site (CCCCACCC) but ex- 
hibits little if any enhancement in myotubes and 
only a two fold enhancement in fibroblasts (clone 
6 - 106/-72 MEK; Fig. 4). Previous deletion anal- 
ysis, however, showed this region to be important 
for promoter activity (Chahine et al., 1992). 
Surprisingly, the region between nt -25 and nt 
+ 10, which spans the E-box and initiator sequence, 
is not sufficient to confer any enhancement or mus- 
cle specificity on MEK promoter activity (clone 6 
-25/+ 10 MEK; Fig. 4) .  In addition, experiments 
using concatamers of three oligos containing the 
SVCE-like sequence exhibited no enhancer activ- 
ity as well (data not shown). Finally, enhancer ex- 
periments using a minimal muscle creatine kinase 
promoter were also performed with similar results, 
indicating that these enhancer effects are not solely 
limited to the MEK promoter (data not shown). 
Previous experiments, mapping the transcrip 
tional start site, confirmed that the &promoter en- 
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Figure 4 Identification of a 47-bp muscle-specific enhancer from the nAChR b-subunit gene 
promoter. Diagram at the top of the figure shows the 102-bp &promoter region with putative 
regulatory elements. based on DMS footprinting and expression assays, indicated by boxes and 
rertanglcs. Below this are diagrams of the various constructs containing fragments of the 6 
promoter subcloned in front of a minimal enkephalin ( M E K )  promoter driving luciferase 
( L u c )  expression. These constructs were transfected into C2CI2 myotubes ( M T )  or NIH3T3 
fibroblastlike cells (FR),  and their level of expression was determined and reported as a per- 
centage of that found for the MEKLuc construct (MEKpXPZ) and as a ratio myoblasts/ 
fibroblast (MB/FB) .  Numbers in parentheses indicate the number of times each experiment 
was repeated. Each experiment was performed in triplicate. SVZCAT DNA was cotransfected 
with all constructs and results were normalized to its expression. Boxes and rectangles repre- 
senting putative regulatory elements are shown to help identify these regulatory sequences 
within the various chimeric promoter constructs and are not necessarily drawn to scale. 
MEK promoter ( Walke et al., 1996). Even construct 
d -25/+ 10 MEK showed initiation at the MEK pro- 
moter, with undetectable initiation within the &pro- 
moter's initiator sequence (indicated by an arrow 
above the initiator sequence in Fig. 4) .  
Site Directed Mutagenesis Identifies 
Sequences throughout 47-bp Enhancer 
that Are Necessary for Muscle-Specific 
Expression 
The mutation and deletion studies indicated that 
the E-box just upstream of the transcription start 
site was necessary for &promoter repression in 
nonmuscle cells (Fig. 3 ) ;  yet this E-box, along with 
downstream promoter sequences, was not suffi- 
cient to confer muscle-specific expression ( 6  -25 1 
+lo,  Fig. 3 and 6 -25/+10 MEK, Fig. 4). There- 
fore, additional elements are likely to be necessary 
for this expression pattern. The enhancer assays 
suggest that these additional elements reside within 
the 47 bp muscle-specific enhancer (Fig. 4).  There- 
fore, mutations were introduced into the enhancer, 
and their effect on muscle-specific expression was 
assayed in C2C 12 myotubes and fibroblasts (Fig. 
5 ). Point mutations in all three of the indicated re- 
nAC'hR 6-Sublinit Gene Muscle Specific Enhancer 367 
m 
6 47/-1 wt TC'MTCCAAACCCCTAAGCCGCCAGCACCTGKCCC'MGCTECCTC 4-
6 47/ -  I SVmUt TC'MTCCMgCCCCTAAGCCGCCAGCACCTGTCCCC'TTZCTTGCCTC 4- 
6 471-1 s p  mut TCTTTCCAAACCCCTAAGCCGtCAGCACCTGTCCCC'MGCTTZCCTC 4 x 1  
6 -471-1 E mUt 1 TC?TTCCA?ACCCCTAAGCCGCCAGgcCCctTCCCC'MGCTTGCCTC 4 I L"C 1 
6 -471-1 E mUt 2 TCTTTCCAAACCCCTAAGCCGCCAGCAtaTGTCCCC'MGCTTGCCTC 4-
6 -37/-1 CCCCTAAGCCGCCAGCACCTTCCCCTTGCTTGCCTC 4-1 
FB 
(2) 
130 f 6 (2) 
220 f 17 (2) 
180 f 7 (2) 
410 f 17 (2) 
140 f 7 (2) 
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Figure 5 Site-directed mutagenesis identifies sequences in the muscle-specific enhancer that 
are necessary to confer muscle-specific enhancement onto a heterologous promoter. Dia- 
grammed are the wild-type and various mutant constructs used in these studies. Top diagram 
shows putative regulatory regions of the &-muscle specific enhancer. Below this are shown the 
DNA sequences of the wild type and various mutations. Mutations are shown in bold and 
lower case type. &Enhancer MEK Luc constructs were cotransfected with SV2CAT into 
C X  I2 myotubes ( M T )  or NIH3T3 fibroblast cells (FB) and assayed for luciferase and CAT 
activity 48 h posttransfection. Results are shown with standard deviations on the right-hand 
side of the figure. Values are represented as a percentage of wild-type expression and as a ratio 
of myotube/fibroblast. Experiments were performed in triplicate and results were normalized 
to  SVZCAT expression. Numbers in parentheses indicate number of repetitions for each ex- 
periment. 
gions led to a significant reduction in the muscle- 
specific enhancer effect, while mutations in the 
Sp I -like and E-box sequence also caused increased 
expression in fibroblast cells. Thus all of these ele- 
ments of d -47 / - 1 appear to be necessary for gen- 
erating a muscle-specific enhancer. Interestingly, 6 
-47 / - 1 E mut 2 is not able to confer musclc-spe- 
cific expression onto the MEK promoter, even 
though the mutation did not eliminate the E-box, 
but merely changed its central, variable nucleo- 
tides. This result suggests that the type of E-box 
embedded in the 47-bp enhancer is critical to its 
function. 
DISCUSSION 
Our experiments identified a 47-bp sequence just 
upstream of the nAChR &subunit gene's transcrip- 
tional start site that can function as a muscle-spe- 
cific enhancer (Fig. 4) .  This enhancer contains 
three putative elements. The most 5' element has 
similarity to the SV40 core enhancer (Khoury and 
Gruss, I983 ), which is followed by an Sp I -like se- 
quence and an E-box. All three of these sequences 
are necessary for muscle-specific expression, be- 
cause point mutations introduced into any of them 
abrogated muscle-specific expression ( Fig. 5 ) . 
The combinatorial action of multiple discreet 
elements functioning as a muscle-specific enhancer 
is not unique to the nAChR &subunit gene. Coop- 
eration between MyoD family members and other 
factors was previously proposed to mediate mus- 
cle-specific expression of a number of muscle genes 
( Sartorelli et al., 1990; Lin et al., 199 1 ; Bessereau 
et al., 1993; Li and Capetanaki, 1994). For exam- 
ple, the muscle-specific expression of the troponin 
1 gene is mediated by an enhancer located in the 
368 Wulke, Xiao, und Goldman 
first intron (Lin et al., 1991). This enhancer con- 
tains three protein binding sites, one of which is an 
E-box and binds MyoD family members. How- 
ever, for full muscle-specific enhancer activity two 
other binding sites are required that bind proteins 
expressed in muscle and nonmuscle cells. Like- 
wise, muscle-specific expression of the nAChR a- 
subunit gene appears to require interactions be- 
tween myogenic factors SP 1 and GBF (Bessereau 
et al., 1993). These putative multiprotein com- 
plexes that form on the enhancer may facilitate in- 
teractions with the basal transcriptional machinery 
ultimately leading to increased promoter activity. 
Within the rat 6-subunit gene’s 47-bp enhancer 
resides an E-box sequence that was previously 
shown to be necessary for muscle-specific expres- 
sion of the mouse &subunit gene (Simon and Bur- 
den, 1993). In that study it was suggested that nu- 
cleotides immediately flanking this E-box or its re- 
lationship to other elements such as enhancer X or 
the initiator sequence may determine its muscle- 
specific properties. Our results with the rat gene 
suggest that the critical sequences determining 
muscle specificity reside within a 47-bp sequence 
that does not include enhancer X or a complete ini- 
tiator sequence. However, based on our mutational 
studies, we suspect that enhancer X can participate 
in muscle-specific expression because mutation of 
this sequence decreased muscle-specific expression 
by about 50% ( 6  -550 slm -81/-65; Fig. 3 ) .  In 
addition, this element may be able to compensate 
for mutations introduced into the SVCE and E-box 
regions as indicated by constructs 6 -550 slm -441 
-29 and 6 -550 slm -21/-5 (Fig. 3).  In these 
cases we found that a mutation in the SVCE or E- 
box region, which abrogated muscle-specific ex- 
pression in our enhancer assays (Fig. 5 ), had only 
a modest affect on myotube expression in the 
context of the 6 promoter (Fig. 3).  Multiple se- 
quences with redundant activities is not uncom- 
mon as illustrated by the nAChR a-subunit pro- 
moter whose Spl site can be replaced by an MEF- 
2 site to activate muscle-specific enhancer activity 
(Bessereau et al., 1993). However, in our studies 
we could not rule out the possibility that these 
differences reflect the different types of mutations 
made in the enhancer versus 6-promoter assays. 
One motivation for characterizing muscle-spe- 
cific expression of the nAChR subunit genes was 
that the mechanisms mediating their induction 
during development may be shared with those me- 
diating their increase following cessation of muscle 
activity. Consistent with this idea is our recent 
finding that this same 47-bp muscle-specific en- 
hancer also functions as an activity-dependent en- 
hancer conferring activity-dependent regulation 
onto a heterologous promoter (Walke et al., 1996). 
In addition, mutational studies of the mouse and 
chick nAChR promoters demonstrated that the 
same E-boxes are necessary for muscle-specific and 
activity-dependent expression (Bessereau et al., 
1994; Tang et al., 1994; Su et al., 1995 ). Although 
these results indicate that the same DNA sequence 
can mediate muscle-specific and activity-depen- 
dent gene expression, it is not clear if similar pro- 
teins bind to these sequences under these different 
conditions. Future experiments will utilize the se- 
quences reported here to begin identifying and 
characterizing their binding proteins. 
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